Investor mix
2 investors on record; lead investors include HMP Global.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 50% |
| Other / undisclosed | 1 | 50% |
Developer of T-cell therapies for viral diseases and cancers
2 investors on record; lead investors include HMP Global.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 50% |
| Other / undisclosed | 1 | 50% |